| 1 |
Li MY, Mi L, Namulinda T, Yan YJ, Zhou XP, Chen ZL. The bromoporphyrins as promising anti-tumor photosensitizers in vitro. Photochem Photobiol Sci 2023;22:427-39. [PMID: 36344865 DOI: 10.1007/s43630-022-00326-9] [Reference Citation Analysis]
|
| 2 |
Tantipanjaporn A, Wong MK. Development and Recent Advances in Lysine and N-Terminal Bioconjugation for Peptides and Proteins. Molecules 2023;28. [PMID: 36770752 DOI: 10.3390/molecules28031083] [Reference Citation Analysis]
|
| 3 |
Nomani A, Kianmehr A, Abdoli S, Javani S. Metal-Based Nanomaterials Photodynamic Action with a Focus on Au and Ag Nanomaterials. Drug Formulation Design [Working Title] 2023. [DOI: 10.5772/intechopen.109220] [Reference Citation Analysis]
|
| 4 |
Sun J, Feng E, Shao Y, Lv F, Wu Y, Tian J, Sun H, Song F. A Selenium-Substituted Heptamethine Cyanine Photosensitizer for Near-Infrared Photodynamic Therapy. Chembiochem 2022;23:e202200421. [PMID: 36149045 DOI: 10.1002/cbic.202200421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Alemayehu AB, Ghosh A. Phenol- and resorcinol-appended metallocorroles and their derivatization with fluorous tags. Sci Rep 2022;12:19256. [PMID: 36357501 DOI: 10.1038/s41598-022-23889-0] [Reference Citation Analysis]
|
| 6 |
Li X, Cao D, Zheng X, Wang G, Liu M. Tissue factor as a new target for tumor therapy-killing two birds with one stone: a narrative review. Ann Transl Med 2022;10:1250. [PMID: 36544632 DOI: 10.21037/atm-22-5067] [Reference Citation Analysis]
|
| 7 |
Mfouo-Tynga IS, Mouinga-Ondeme AG. Photodynamic Therapy: A Prospective Therapeutic Approach for Viral Infections and Induced Neoplasia. Pharmaceuticals (Basel) 2022;15:1273. [PMID: 36297385 DOI: 10.3390/ph15101273] [Reference Citation Analysis]
|
| 8 |
Iacopini D, Vančo J, Di Pietro S, Bordoni V, Zacchini S, Marchetti F, Dvořák Z, Malina T, Biancalana L, Trávníček Z, Di Bussolo V. New glycoconjugation strategies for Ruthenium(II) arene complexes via phosphane ligands and assessment of their antiproliferative activity. Bioorganic Chemistry 2022;126:105901. [DOI: 10.1016/j.bioorg.2022.105901] [Reference Citation Analysis]
|
| 9 |
Didamson OC, Abrahamse H. Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine. Pharmaceutics 2021;13:1943. [PMID: 34834358 DOI: 10.3390/pharmaceutics13111943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Dhaini B, Kenzhebayeva B, Ben-mihoub A, Gries M, Acherar S, Baros F, Thomas N, Daouk J, Schohn H, Hamieh T, Frochot C. Peptide-conjugated nanoparticles for targeted photodynamic therapy. Nanophotonics 2021;10:3089-134. [DOI: 10.1515/nanoph-2021-0275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 11 |
Algorri JF, Ochoa M, Roldán-Varona P, Rodríguez-Cobo L, López-Higuera JM. Photodynamic Therapy: A Compendium of Latest Reviews. Cancers (Basel) 2021;13:4447. [PMID: 34503255 DOI: 10.3390/cancers13174447] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 12 |
Mo J, Mai Le NP, Priefer R. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers. Eur J Med Chem 2021;225:113770. [PMID: 34403979 DOI: 10.1016/j.ejmech.2021.113770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Zhang PJ, Liu MD, Fan FY, Liu KX. A Study on Mesoporous Silica Loaded With Novel Photosensitizers HCE6 and Oxaliplatin for the Treatment of Cholangiocarcinoma. Front Oncol 2021;11:665182. [PMID: 34268112 DOI: 10.3389/fonc.2021.665182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Mochizuki C, Nakamura J, Nakamura M. Development of Non-Porous Silica Nanoparticles towards Cancer Photo-Theranostics. Biomedicines 2021;9:73. [PMID: 33451074 DOI: 10.3390/biomedicines9010073] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 15 |
Hu Z. Using CAR-NK cells to overcome the host resistance to antibody immunotherapy and immune checkpoint blockade therapy. Successes and Challenges of NK Immunotherapy 2021. [DOI: 10.1016/b978-0-12-824375-6.00010-2] [Reference Citation Analysis]
|
